IGM Biosciences Inc: Will Retain Global Rights to Its Proprietary Technology Related to Oncology Targets Nominated by Sanofi Under Collaboration
IGM Biosciences Inc:将保留其与赛诺菲合作提名的肿瘤靶点相关的专有技术的全球版权
IGM Biosciences Inc: Will Retain Global Rights to Its Proprietary Technology Related to Oncology Targets Nominated by Sanofi Under Collaboration
IGM Biosciences Inc:将保留其与赛诺菲合作提名的肿瘤靶点相关的专有技术的全球版权
使用浏览器的分享功能,分享给你的好友吧